Mathematics Faculty Proceedings, Presentations, Speeches, Lectures

Statistically significant association of glioblastoma immunotherapy phase II clinical study (ICT-107) treatment and survival to immune response using a novel comprehensive ELISPOT analysis.

Event Name/Location

The 20th Annual Scientific Meeting and Education Day for the Society for Neuro-Oncology; 2015 November 19-22; San Antonio, TX

Presentation Date

11-2015

Document Type

Poster

This document is currently not available here.

Share

COinS